Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from New China Life Insurance Co., Ltd. Class H ( (HK:1336) ).
New China Life Insurance Co., Ltd. has announced the current composition of its board of directors, confirming Yang Yucheng as chairman and executive director, alongside one other executive director, four non-executive directors and four independent non-executive directors. The insurer has also detailed the membership and chairmanship of its five key board committees covering strategy and ESG, investment and asset-liability management, audit and related-party transactions, nomination and remuneration, and risk management and consumer rights protection. The appointment of Sau Fun Cheung as an independent non-executive director and as a member of several board committees will take effect once ratified by regulators, with incumbent independent non-executive director Ma Yiu Tim continuing to serve in the interim, indicating a controlled and compliant transition in the company’s governance framework.
The most recent analyst rating on (HK:1336) stock is a Buy with a HK$60.00 price target. To see the full list of analyst forecasts on New China Life Insurance Co., Ltd. Class H stock, see the HK:1336 Stock Forecast page.
More about New China Life Insurance Co., Ltd. Class H
New China Life Insurance Co., Ltd. is a major life insurer incorporated in the People’s Republic of China and listed in Hong Kong, focusing on life insurance and related financial protection services. The company operates under a board structure that includes executive, non-executive and independent non-executive directors, supported by specialized committees overseeing strategy, ESG, investment, audit, remuneration, risk management and consumer rights protection.
Average Trading Volume: 13,121,771
Technical Sentiment Signal: Buy
Current Market Cap: HK$221.8B
For detailed information about 1336 stock, go to TipRanks’ Stock Analysis page.

